ScholarIQanswers from OpenAlex & ORCID
Richard J. Barohn
ResearcherPublications, citations & collaboration network
Richard J. Barohn is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Richard J. Barohn have?
ScholarIQindexed works
Richard J. Barohn has 346 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Richard J. Barohn have?
ScholarIQcitation count
Richard J. Barohn has 22,439 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Richard J. Barohn?
ScholarIQh-index
Richard J. Barohn has an h-index of 79 in OpenAlex.
What is the i10-index of Richard J. Barohn?
ScholarIQi10-index
Richard J. Barohn has an i10-index of 188 in OpenAlex.
What is the OpenAlex record for Richard J. Barohn?
ScholarIQopenalex
The OpenAlex for Richard J. Barohn is on the source record.
What are the most-cited papers on Richard J. Barohn?
ScholarIQmost cited works
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Ingrid E. Lundberg, Anna Tjärnlund, Matteo Bottai, Victoria P. Werth, Clarissa Pilkington, Marianne de Visser, Lars Alfredsson, Anthony A. Amato, Richard J. Barohn, Matthew H. Liang, Jasvinder A. Singh, Rohit Aggarwal, Snjólaug Arnardottir, Hector Chinoy, Robert G. Cooper, Katalin Dankó, Mazen M. Dimachkie, Brian M. Feldman, Ignacio García‐De La Torre, Patrick Gordon, Taichi Hayashi, James D. Katz, Hitoshi Kohsaka, Peter A. Lachenbruch, Bianca Lang, Yuhui Li, Chester V. Oddis, Marzena Olesińska, Ann M. Reed, Lidia Rutkowska‐Sak, Helga Sanner, Albert Selva-O’Callaghan, Yeong‐Wook Song, Jiří Vencovský, Steven R. Ytterberg, Frederick W. Miller, Lisa G. Rider
2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
Ingrid E. Lundberg, Anna Tjärnlund, Matteo Bottai, Victoria P. Werth, Clarissa Pilkington, Marianne de Visser, Lars Alfredsson, Anthony A. Amato, Richard J. Barohn, Matthew H. Liang, Jasvinder A. Singh, Rohit Aggarwal, Snjólaug Arnardottir, Hector Chinoy, Robert G. Cooper, Katalin Dankó, Mazen M. Dimachkie, Brian M. Feldman, Ignacio García‐De La Torre, Patrick Gordon, Taichi Hayashi, James D. Katz, Hitoshi Kohsaka, Peter A. Lachenbruch, Bianca Lang, Yuhui Li, Chester V. Oddis, Marzena Olesińska, Ann M. Reed, Lidia Rutkowska‐Sak, Helga Sanner, Albert Selva-O’Callaghan, Yeong‐Wook Song, Jiří Vencovský, Steven R. Ytterberg, Frederick W. Miller, Lisa G. Rider
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H Gordon, Dan H. Moore, Robert G. Miller, Julaine Florence, Joseph L. Verheijde, Carolyn Doorish, Joan F. Hilton, G. Mark Spitalny, Robert B. MacArthur, Hiroshi Mitsumoto, Hans E. Neville, Khrista Boylan, Tahseen Mozaffar, Jerry M. Belsh, John Ravits, Richard Bedlack, Michael C. Graves, Leo McCluskey, Richard J. Barohn, Rup Tandan
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Craig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli, Richard S. Finkel, Kevin M. Flanigan, Nathalie Goemans, Peter Heydemann, Anna Kamińska, Janbernd Kirschner, Francesco Muntoni, A. Nascimento Osorio, Ulrike Schara, Thomas Sejersen, Perry B. Shieh, H. Lee Sweeney, Haluk Topaloğlu, M. Tulinius, Juan J. Vílchez, Thomas Voït, Brenda Wong, Gary Elfring, Hans Kröger, Xiaohui Luo, Joseph McIntosh, Tuyen Ong, Peter Riebling, Marcio Ferreira de Souza, Robert J. Spiegel, Stuart W. Peltz, Eugenio Mercuri, Lindsay N. Alfano, Michelle Eagle, M. James, Linda Lowes, Anna Mayhew, Elena Mazzone, Leslie Nelson, Kristy Rose, Hoda Abdel‐Hamid, Susan Apkon, Richard J. Barohn, Enrico Bertini, Clemens Bloetzer, Lausanne Canton de Vaud, Russell J. Butterfield, B. Chabrol, Jong‐Hee Chae, Daehak-ro Jongno-gu, Giacomi Pietro Comi, Basil T. Darras, Jahannaz Dastgir, Isabelle Desguerre, Raúl G. Escobar, Erika Finanger, Michela Guglieri, Imelda Hughes, Susan T. Iannaccone, Kristi Jones, Peter Karachunski, Martin Kudr, Timothy Lotze, Jean K. Mah, Katherine D. Mathews, Yoram Nevo, Julie Parsons, Yann Péréon, Alexandra Prufer de Queiroz Campos Araújo, J. Ben Renfroe, Maria Bernadete Dutra de Resende, Monique M. Ryan, Kathryn Selby, Gihan Tennekoon, Giuseppe Vita
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C‐HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF‐36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index‐2 (FI‐2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)
Lisa G. Rider, Victoria P. Werth, Adam M. Huber, Helene Alexanderson, Anand Rao, Nicolino Ruperto, Laura Herbelin, Richard J. Barohn, David Isenberg, Frederick W. Miller